Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Webb

Showing results (201-210 of 323) with videos related to

Pageof 33
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 2, 2011
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney diseaseNeeraj Dhaun, Iain M MacIntyre, Debbie Kerr, et al.
High Altitude Medicine & Biology|September 19, 2006
Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitudeEve M D Smith, J Kenneth Baillie, A A Roger Thompson, et al.
Hypertension (Dallas, Tex. : 1979)|July 21, 2004
Nebivolol increases arterial distensibility in vivoCarmel M McEniery, Matthias Schmitt, Ahmad Qasem, et al.
The British Journal of Nutrition|May 25, 2013
Effect of polyphenol-rich grape seed extract on ambulatory blood pressure in subjects with pre- and stage I hypertensionRouyanne T Ras, Peter L Zock, Yvonne E M P Zebregs, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 25, 2014
Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associationsNeeraj Dhaun, Jean-Luc Vachiery, Raymond L Benza, et al.
Circulation|February 26, 2004
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockadeJane Goddard, Neil R Johnston, Malcolm F Hand, et al.
American Journal of Physiology. Renal Physiology|March 13, 2009
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritisNeeraj Dhaun, Pajaree Lilitkarntakul, Iain M Macintyre, et al.
Pharmacoepidemiology and Drug Safety|August 7, 2019
Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial dataMatthew Sperrin, David J Webb, Pinal Patel, et al.
Journal of Lipid Research|November 27, 2014
Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney diseaseAna Reis, Alisa Rudnitskaya, Pajaree Chariyavilaskul, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 26, 2021
Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational StudiesThomas M Caparrotta, Jack B Templeton, Thomas A Clay, et al.
Pageof 33

Showing results (201-210 of 323) with videos related to

Sort By:
Pageof 33
Hypertension (Dallas, Tex. : 1979)|March 2, 2011
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney diseaseNeeraj Dhaun, Iain M MacIntyre, Debbie Kerr, et al.
High Altitude Medicine & Biology|September 19, 2006
Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitudeEve M D Smith, J Kenneth Baillie, A A Roger Thompson, et al.
Hypertension (Dallas, Tex. : 1979)|July 21, 2004
Nebivolol increases arterial distensibility in vivoCarmel M McEniery, Matthias Schmitt, Ahmad Qasem, et al.
The British Journal of Nutrition|May 25, 2013
Effect of polyphenol-rich grape seed extract on ambulatory blood pressure in subjects with pre- and stage I hypertensionRouyanne T Ras, Peter L Zock, Yvonne E M P Zebregs, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 25, 2014
Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associationsNeeraj Dhaun, Jean-Luc Vachiery, Raymond L Benza, et al.
Circulation|February 26, 2004
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockadeJane Goddard, Neil R Johnston, Malcolm F Hand, et al.
American Journal of Physiology. Renal Physiology|March 13, 2009
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritisNeeraj Dhaun, Pajaree Lilitkarntakul, Iain M Macintyre, et al.
Pharmacoepidemiology and Drug Safety|August 7, 2019
Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial dataMatthew Sperrin, David J Webb, Pinal Patel, et al.
Journal of Lipid Research|November 27, 2014
Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney diseaseAna Reis, Alisa Rudnitskaya, Pajaree Chariyavilaskul, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 26, 2021
Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational StudiesThomas M Caparrotta, Jack B Templeton, Thomas A Clay, et al.
Pageof 33